This review summarizes the available evidence on the association between pericardial effusion and pulmonary arterial hypertension, highlighting the need for future research on its management.
Answers are grounded in this paper and cite their sources.
Pericardial effusion in PAH lacks management guidance; leaves open need for prospective trials.
Pulmonary arterial hypertension (PAH) is a serious condition that can lead to right heart failure and death. Pericardial effusion in PAH is associated with significant morbidity and mortality, and its pathogenesis is complex and poorly understood. There are few data on the prevalence of pericardial effusion in PAH, and more importantly, the management of pericardial effusion is controversial. Current literature abounds with case reports, case series, and retrospective studies that have limited value for assessing this association. Hence, we summarize the available evidence on this ominous association and identify areas for future research.
No takes yet. Share an insight, caveat, or question.
Sahay et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: